LOS ANGELES--(BUSINESS WIRE)--$RECAF #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. (“ReconAfrica” or the “Company”) (OTC: RECAF, formerly LGDOF) investors concerning the Company’s possible violations of the federal securities laws. If […]
LOS ANGELES--(BUSINESS WIRE)--$HON #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Honeywell International Inc. (“Honeywell” or the “Company”) (NASDAQ: HON) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Honeywell […]
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Höegh LNG Partners LP (NYSE: HMLP) between August 22, 2019 and July 27, 2021, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Höegh investors under […]
NEW YORK--(BUSINESS WIRE)--#BioMarin--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against BioMarin Pharmaceuticals (“BioMarin” or the “Company”) (NASDAQ: BMRN) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise […]
NEW YORK--(BUSINESS WIRE)--#Securities--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Snap, Inc. (“Snap” or the “Company”) (NYSE: SNAP) on behalf of Snap stockholders. Our investigation concerns whether Snap has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in […]
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you […]
LOS ANGELES--(BUSINESS WIRE)--$BMRN #BMRN--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BioMarin Pharmaceutical Inc. (“BioMarin” or “the Company”) (NASDAQ: BMRN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. […]
MENLO PARK, Calif.--(BUSINESS WIRE)--#biomarkers--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the issuance of two key US Patents related to its high-performance, exome-wide liquid biopsy platform, NeXT Liquid Biopsy™. The first patent, US Patent No. 11,142,802, entitled “Methods for Using Mosaicism in Nucleic Acids Sampled Distal to Their Origin”, issued […]
SAN DIEGO--(BUSINESS WIRE)--#RECAFstock--Robbins Geller Rudman & Dowd LLP announces that purchasers of Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. (“ReconAfrica”) (OTCMKTS: RECAF; LGDOF) publicly traded securities between February 28, 2019 and September 7, 2021, inclusive (the “Class Period”) have until December 27, 2021 to seek appointment as lead plaintiff in Muller v. Reconnaissance Energy […]
LOS ANGELES--(BUSINESS WIRE)--$SAVA #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Western District of Texas captioned Rao v. Cassava Sciences, Inc., et al., (Case No. 1:21-cv-00971) on behalf of persons and entities that purchased or otherwise acquired Cassava Sciences, Inc. […]
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent
